Abstract:Background: CD147 plays a pivotal in the process of many malignancies. It remains unclear whether CD147 expression has clinical significance with cervical lesions. The current research was aimed to assess the expression of CD147 and investigate its relevance with the tumorigenesis and clinicopathological progression of cervical cancer. Materials and methods: Immunohistochemistry was conducted to evaluate the expression of CD147 within a total of 494 cases of cervical lesions, which were composed of chronic cervicitis (n=54), condyloma acuminatum (CA, n=42), carcinoma in situ (CIS, n=38), adenocarcinoma (n=63), squamous cell carcinoma (SCC, n=263) and adenosquamous carcinoma (n=34). SPSS 22.0 was used to analyze the relationship of CD147 expression and clinicopathological features of cervical lesions. CBioPortal was used to assess the OncoPrint of CD147 based on the data from The Cancer Genome Atlas (TCGA), and the prognostic value of CD147 in cervical cancer was shown by Oncolnc. Results: CD147 expression showed a positive rate of 22.2%, 31.0%, 42.1%, 55.6%, 66.5% and 64.7% from chronic cervicitis, CA, CIS to adenocarcinoma, SCC and adenosquamous carcinoma, respectively. CD147 expression level was statistically higher in cancer than non-cancerous tissues (P<0.001). Results from Spearman correlation test confirmed that CD147 had positive correlation with age, lymph node metastasis, FIGO stage, TNM stage, as well as pathological grade (all P<0.05) in adenocarcinoma. As for SCC, CD147 was positively related to lymph node metastasis, FIGO stage, TNM stage and pathological grade (all P<0.001). In adenosquamous carcinoma, a positive correlation was observed between CD147 and lymph node metastasis, FIGO stage and TNM stage (all P<0.05). Furthermore, Gene alteration of 79 among 307 cases (26%) was shown by CBioPortal based on RNA-seq data. Conclusions: CD147 may have a significant effect on the tumorigenesis and progression of cervical cancer, and it is anticipated to be a potential diagnostic and therapeutic biomarker.

Involvement of CD147 Isoform‑4 in the Proliferation of SiHa Cells: a Possible Molecular Mechanism of Cervical Cancer.

CD 147 and HPV 16 oncoprotein expression in cervical squamous cell carcinoma and the clinical implications

Expression of CD147 Protein in Human Cervical Carcinoma

Expression of CD147 in Advanced Non-Small Cell Lung Cancer Correlated with Cisplatin-Based Chemotherapy Resistance.

Inhibition of the Expression of CD147 by MicroRNA and Influence on the Biological Activities of Tumor in SiHa

Over-expressed CD 147 may be a reminder of tumor progression in cervical lesions : an immunohistochemical investigation with 494 cases

Altered expression of cellular membrane molecules of HLA-DR, HLA-G and CD99 in cervical intraepithelial neoplasias and invasive squamous cell carcinoma.

CD147 overexpression promotes tumorigenicity in Chinese hamster ovary cells

[Highly Expressed CD147 on CD4⁺ Tumor Infiltrating Lymphocytes Promotes the Progress of Breast Cancer].

Altered Expression Levels of Hla Class Ii and Costimulatory Molecules on Circulating Monocytes from Patients with Cervical Intraepithelial Neoplasia and Squamous Cervical Cancer

CNN3 Acts As a Potential Oncogene in Cervical Cancer by Affecting RPLP1 Mrna Expression

The Involvement of P53-Mir-34a-cdk4 Signaling During the Development of Cervical Cancer

CD147 promotes progression of head and neck squamous cell carcinoma via NF-kappa B signaling.

RNA interference targeting extracellular matrix metalloproteinase inducer (CD147) inhibits growth and increases chemosensitivity in human cervical cancer cells.

CD 24 Promotes the Proliferation and Inhibits the Apoptosis of Cervical Cancer Cells in Vitro

Extracellular matrix metalloproteinase inducer (CD147/BSG/EMMPRIN)-induced radioresistance in cervical cancer by regulating the percentage of the cells in the G2/m phase of the cell cycle and the repair of DNA Double-strand Breaks (DSBs).

RNAi-mediated silencing of CD147 inhibits tumor cell proliferation, invasion and increases chemosensitivity to cisplatin in SGC7901 cells in vitro

Molecular Mechanism of Skp2 in Promoting Cervical Cancer HeLa Cell Proliferation

Involvement of CD147 in Regulation of Multidrug Resistance to P‐gp Substrate Drugs and in Vitro Invasion in Breast Cancer Cells

CD147 silencing via RNA interference reduces tumor cell invasion, metastasis and increases chemosensitivity in pancreatic cancer cells.

CD147 promotes proliferation and migration of oral cancer cells by inhibiting junctions between E-cadherin and β-catenin